PD-1/L1 inhibitors may increase the risk of pericardial disease in non-small-cell lung cancer patients: a meta-analysis and systematic review

Immunotherapy, Ahead of Print.

Source: Immunotherapy - April 4, 2022 Category: Allergy & Immunology Authors: Honglin Li Deting Han Lei Zhang Xiaoteng Feng Huijie Li Feiran Yang Lucheng Song Xiurong Li Source Type: research